Logo image of LFMDP

LIFEMD INC - LFMD 8 7/8 PERP (LFMDP) Stock Fundamental Analysis

NASDAQ:LFMDP - Nasdaq - US53216B2034 - Currency: USD

23.67  +0.42 (+1.81%)

Fundamental Rating

4

Taking everything into account, LFMDP scores 4 out of 10 in our fundamental rating. LFMDP was compared to 36 industry peers in the Health Care Technology industry. LFMDP may be in some trouble as it scores bad on both profitability and health. LFMDP is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year LFMDP has reported negative net income.
In the past year LFMDP had a positive cash flow from operations.
LFMDP had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: LFMDP reported negative operating cash flow in multiple years.
LFMDP Yearly Net Income VS EBIT VS OCF VS FCFLFMDP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M

1.2 Ratios

LFMDP's Return On Assets of -18.79% is in line compared to the rest of the industry. LFMDP outperforms 47.22% of its industry peers.
Industry RankSector Rank
ROA -18.79%
ROE N/A
ROIC N/A
ROA(3y)-86.73%
ROA(5y)-171.43%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LFMDP Yearly ROA, ROE, ROICLFMDP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K

1.3 Margins

LFMDP has a better Gross Margin (87.99%) than 91.67% of its industry peers.
LFMDP's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for LFMDP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 87.99%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.22%
GM growth 5Y3.8%
LFMDP Yearly Profit, Operating, Gross MarginsLFMDP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

3

2. Health

2.1 Basic Checks

LFMDP does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, LFMDP has more shares outstanding
LFMDP has more shares outstanding than it did 5 years ago.
LFMDP has a better debt/assets ratio than last year.
LFMDP Yearly Shares OutstandingLFMDP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
LFMDP Yearly Total Debt VS Total AssetsLFMDP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

LFMDP has an Altman-Z score of 6.53. This indicates that LFMDP is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 6.53, LFMDP belongs to the best of the industry, outperforming 86.11% of the companies in the same industry.
LFMDP has a debt to FCF ratio of 5.81. This is a neutral value as LFMDP would need 5.81 years to pay back of all of its debts.
LFMDP has a better Debt to FCF ratio (5.81) than 63.89% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 5.81
Altman-Z 6.53
ROIC/WACCN/A
WACC9.94%
LFMDP Yearly LT Debt VS Equity VS FCFLFMDP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M

2.3 Liquidity

LFMDP has a Current Ratio of 0.82. This is a bad value and indicates that LFMDP is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.82, LFMDP is not doing good in the industry: 83.33% of the companies in the same industry are doing better.
LFMDP has a Quick Ratio of 0.82. This is a bad value and indicates that LFMDP is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.77, LFMDP is doing worse than 83.33% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.82
Quick Ratio 0.77
LFMDP Yearly Current Assets VS Current LiabilitesLFMDP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 54.05% over the past year.
The Revenue has grown by 43.07% in the past year. This is a very strong growth!
LFMDP shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 76.23% yearly.
EPS 1Y (TTM)54.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%105.26%
Revenue 1Y (TTM)43.07%
Revenue growth 3Y31.75%
Revenue growth 5Y76.23%
Sales Q2Q%48.83%

3.2 Future

The Earnings Per Share is expected to grow by 41.15% on average over the next years. This is a very strong growth
Based on estimates for the next years, LFMDP will show a very strong growth in Revenue. The Revenue will grow by 25.78% on average per year.
EPS Next Y95.09%
EPS Next 2Y58.88%
EPS Next 3Y41.15%
EPS Next 5YN/A
Revenue Next Year31.3%
Revenue Next 2Y24.42%
Revenue Next 3Y25.78%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
LFMDP Yearly Revenue VS EstimatesLFMDP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M
LFMDP Yearly EPS VS EstimatesLFMDP Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.5 -1 -1.5 -2

3

4. Valuation

4.1 Price/Earnings Ratio

LFMDP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
LFMDP is valuated quite expensively with a Price/Forward Earnings ratio of 83.62.
Compared to the rest of the industry, the Price/Forward Earnings ratio of LFMDP indicates a somewhat cheap valuation: LFMDP is cheaper than 61.11% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of LFMDP to the average of the S&P500 Index (22.06), we can say LFMDP is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 83.62
LFMDP Price Earnings VS Forward Price EarningsLFMDP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of LFMDP is on the same level as its industry peers.
LFMDP's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 339.39
EV/EBITDA 397.43
LFMDP Per share dataLFMDP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as LFMDP's earnings are expected to grow with 41.15% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y58.88%
EPS Next 3Y41.15%

4

5. Dividend

5.1 Amount

LFMDP has a Yearly Dividend Yield of 9.24%, which is a nice return.
Compared to an average industry Dividend Yield of 37.37, LFMDP pays a better dividend. On top of this LFMDP pays more dividend than 97.22% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.38, LFMDP pays a better dividend.
Industry RankSector Rank
Dividend Yield 9.24%

5.2 History

LFMDP has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years1
LFMDP Yearly Dividends per shareLFMDP Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

The earnings of LFMDP are negative and hence is the payout ratio. LFMDP will probably not be able to sustain this dividend level.
DP-22.45%
EPS Next 2Y58.88%
EPS Next 3Y41.15%
LFMDP Yearly Income VS Free CF VS DividendLFMDP Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M

LIFEMD INC - LFMD 8 7/8 PERP

NASDAQ:LFMDP (6/6/2025, 10:30:03 AM)

23.67

+0.42 (+1.81%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)05-06 2025-05-06/amc
Earnings (Next)08-05 2025-08-05/amc
Inst Owners37.55%
Inst Owner ChangeN/A
Ins Owners15.43%
Ins Owner ChangeN/A
Market Cap1.08B
Analysts81.33
Price Target40.1 (69.41%)
Short Float %0%
Short Ratio0.14
Dividend
Industry RankSector Rank
Dividend Yield 9.24%
Yearly Dividend0.08
Dividend Growth(5Y)N/A
DP-22.45%
Div Incr Years0
Div Non Decr Years1
Ex-Date04-04 2025-04-04 (0.5546875)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)90.21%
Min EPS beat(2)61.87%
Max EPS beat(2)118.55%
EPS beat(4)2
Avg EPS beat(4)28.94%
Min EPS beat(4)-49.02%
Max EPS beat(4)118.55%
EPS beat(8)3
Avg EPS beat(8)-4.25%
EPS beat(12)5
Avg EPS beat(12)-13.27%
EPS beat(16)6
Avg EPS beat(16)-14.35%
Revenue beat(2)2
Avg Revenue beat(2)6.37%
Min Revenue beat(2)2.97%
Max Revenue beat(2)9.78%
Revenue beat(4)3
Avg Revenue beat(4)3.24%
Min Revenue beat(4)-2.71%
Max Revenue beat(4)9.78%
Revenue beat(8)6
Avg Revenue beat(8)2.84%
Revenue beat(12)7
Avg Revenue beat(12)0.03%
Revenue beat(16)7
Avg Revenue beat(16)-0.97%
PT rev (1m)-22.27%
PT rev (3m)-22.73%
EPS NQ rev (1m)55.78%
EPS NQ rev (3m)60%
EPS NY rev (1m)53.33%
EPS NY rev (3m)35%
Revenue NQ rev (1m)0.84%
Revenue NQ rev (3m)5.05%
Revenue NY rev (1m)0.43%
Revenue NY rev (3m)4.97%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 83.62
P/S 4.6
P/FCF 339.39
P/OCF 69.95
P/B N/A
P/tB N/A
EV/EBITDA 397.43
EPS(TTM)-0.34
EYN/A
EPS(NY)0.28
Fwd EY1.2%
FCF(TTM)0.07
FCFY0.29%
OCF(TTM)0.34
OCFY1.43%
SpS5.15
BVpS-0.05
TBVpS-0.41
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -18.79%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 87.99%
FCFM 1.35%
ROA(3y)-86.73%
ROA(5y)-171.43%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.22%
GM growth 5Y3.8%
F-Score5
Asset Turnover3.18
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 5.81
Debt/EBITDA 2.6
Cap/Depr 121.5%
Cap/Sales 5.22%
Interest Coverage N/A
Cash Conversion 587.29%
Profit Quality N/A
Current Ratio 0.82
Quick Ratio 0.77
Altman-Z 6.53
F-Score5
WACC9.94%
ROIC/WACCN/A
Cap/Depr(3y)162.46%
Cap/Depr(5y)195.18%
Cap/Sales(3y)6.18%
Cap/Sales(5y)4.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)54.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%105.26%
EPS Next Y95.09%
EPS Next 2Y58.88%
EPS Next 3Y41.15%
EPS Next 5YN/A
Revenue 1Y (TTM)43.07%
Revenue growth 3Y31.75%
Revenue growth 5Y76.23%
Sales Q2Q%48.83%
Revenue Next Year31.3%
Revenue Next 2Y24.42%
Revenue Next 3Y25.78%
Revenue Next 5YN/A
EBIT growth 1Y58.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year274.77%
EBIT Next 3Y72.64%
EBIT Next 5YN/A
FCF growth 1Y112.29%
FCF growth 3YN/A
FCF growth 5Y88.7%
OCF growth 1Y188.08%
OCF growth 3YN/A
OCF growth 5Y133.93%